Context: Chromogranin A (CgA) is a novel biomarker with potential to assess mortality risk of patients with severe sepsis.Objective: Assess association of CgA levels and mortality risk of severely septic patients.Methods: Serum CgA levels were measured in 50 hospitalized, severely septic patients with organ failure <48 h.Results: Higher CgA levels trended toward higher ICU and hospital mortality. Patients without cardiovascular disease who died in the ICU had higher median (IQR) CgA levels 602.3 (343.3, 1134.3) ng/ml versus 205.5 (130.7, 325.9) ng/ml, p = 0.01.Conclusions: High CgA levels predict ICU mortality in severely septic patients without prior cardiovascular disease.

Chromogranin A levels and mortality in patients with severe sepsis / C. Hsu, L.F. Reyes, C.J. Orihuela, R. Buitrago, A. Anzueto, N.J. Soni, S. Levine, J. Peters, C.A. Hinojosa, S. Aliberti, O. Sibila, A. Rodriguez, J.D. Chalmers, I. Martin Loeches, J. Bordon, J. Blanquer, F. Sanz, P.J. Marcos, J. Rello, J. Solé Violán, M.I. Restrepo. - In: BIOMARKERS. - ISSN 1354-750X. - 20:3(2015), pp. 171-176. [10.3109/1354750X.2015.1046932]

Chromogranin A levels and mortality in patients with severe sepsis

S. Aliberti;
2015

Abstract

Context: Chromogranin A (CgA) is a novel biomarker with potential to assess mortality risk of patients with severe sepsis.Objective: Assess association of CgA levels and mortality risk of severely septic patients.Methods: Serum CgA levels were measured in 50 hospitalized, severely septic patients with organ failure <48 h.Results: Higher CgA levels trended toward higher ICU and hospital mortality. Patients without cardiovascular disease who died in the ICU had higher median (IQR) CgA levels 602.3 (343.3, 1134.3) ng/ml versus 205.5 (130.7, 325.9) ng/ml, p = 0.01.Conclusions: High CgA levels predict ICU mortality in severely septic patients without prior cardiovascular disease.
Biological marker; cardiovascular diseases; Chromogranin A; mortality; sepsis; Aged; Biomarkers; Chromogranin A; Cohort Studies; Female; Hospital Mortality; Humans; Intensive Care Units; Male; Middle Aged; Multiple Organ Failure; Prognosis; Sepsis; Survival Analysis; Biochemistry; Clinical Biochemistry; Health, Toxicology and Mutagenesis
Settore MED/10 - Malattie dell'Apparato Respiratorio
2015
Article (author)
File in questo prodotto:
File Dimensione Formato  
1354750X.2015.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 549.21 kB
Formato Adobe PDF
549.21 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/434395
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 8
  • ???jsp.display-item.citation.isi??? 9
social impact